Literature DB >> 10533766

Subcutaneous tissue oxygen and carbon dioxide tensions during hyperbaric oxygenation: an experimental study in rats.

K Korhonen1, K Kuttila, J Niinikoski.   

Abstract

OBJECTIVE: To investigate the response of subcutaneous tissue oxygen (O2) and carbon dioxide (CO2) tensions to hyperbaric oxygenation.
DESIGN: Experimental study.
SETTING: University hospital, Finland.
SUBJECTS: 10 Wistar rats. INTERVENTION: Subcutaneous tissue PO2 and PCO2 were directly measured with an implanted Silastic tube tonometer and capillary sampling technique while breathing air and exposed to hyperbaric oxygen (HBO) at 2.5 or 2.8 ATA pressure. Hyperbaric exposures were carried out in a large multiplace chamber pressurised with air. MAIN OUTCOME MEASURES: Subcutaneous tissue PO2 and PCO2.
RESULTS: The mean subcutaneous PO2 rose from the baseline of 8 kPa (60 mmHg) to 16 kPa (112 mmHg) when rats breathed room air during pressurisation to 2.8 atm. When the rats breathed oxygen at 2.5 ATA the maximal mean tissue PO2 was four times higher than the mean starting value. During the HBO treatment at 2.8 ATA the tissue PO2 rose to a value about five times above baseline. The tissue PCO2 values almost doubled during the exposure to HBO at 2.5 ATA, probably because elimination of carbon dioxide was impaired.
CONCLUSION: Measurements of tissue PO2 and PCO2 with an implanted Silastic tonometer and a capillary sampling technique can successfully be adapted to hyperbaric conditions. The method yielded reproducible results and is applicable to clinical use in hyperbaric medicine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533766     DOI: 10.1080/11024159950189401

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  7 in total

1.  Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample.

Authors:  Chai R Soh; Ricardo Pietrobon; John J Freiberger; Sophia T Chew; Dimple Rajgor; Mihir Gandhi; Jatin Shah; Richard E Moon
Journal:  Intensive Care Med       Date:  2012-04-20       Impact factor: 17.440

2.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

3.  Effect of Hyperbaric Oxygen on Proliferation and Gene Expression of Human Chondrocytes: An In Vitro Study.

Authors:  Carolin Melcher; Birte Sievers; Nadine Höchsmann; Frank Düren; Volkmar Jansson; Peter E Müller
Journal:  Cartilage       Date:  2018-03-27       Impact factor: 4.634

Review 4.  Wound healing essentials: let there be oxygen.

Authors:  Chandan K Sen
Journal:  Wound Repair Regen       Date:  2009 Jan-Feb       Impact factor: 3.617

5.  Effects of hyperbaric oxygen on the osteogenic differentiation of mesenchymal stem cells.

Authors:  Song-Shu Lin; Steve Wn Ueng; Chi-Chien Niu; Li-Jen Yuan; Chuen-Yung Yang; Wen-Jer Chen; Mel S Lee; Jan-Kan Chen
Journal:  BMC Musculoskelet Disord       Date:  2014-02-25       Impact factor: 2.362

6.  Mir-573 regulates cell proliferation and apoptosis by targeting Bax in human degenerative disc cells following hyperbaric oxygen treatment.

Authors:  Song-Shu Lin; Chi-Chien Niu; Li-Jen Yuan; Tsung-Ting Tsai; Po-Liang Lai; Kowit-Yu Chong; Kuo-Chen Wei; Chiung-Yin Huang; Meng-Ling Lu; Chuen-Yung Yang; Steve W N Ueng
Journal:  J Orthop Surg Res       Date:  2021-01-07       Impact factor: 2.359

7.  Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells.

Authors:  Chi-Chien Niu; Song-Shu Lin; Li-Jen Yuan; Meng-Ling Lu; Steve W N Ueng; Chuen-Yung Yang; Tsung-Ting Tsai; Po-Liang Lai
Journal:  Arthritis Res Ther       Date:  2019-01-31       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.